1α,25-Dihydroxy-2β(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora

Bone

Volumn 40, Issue 1, 2007, Pages 132-139

  Cao, Yongping ^a,b   Mori, Satoshi ^a   Mashiba, Tasuku ^a   Kaji, Yoshio ^a   Manabe, Takeshi ^a   Iwata, Ken ^a   Miyamoto, Kensaku ^a   Komatsubara, Satoshi ^a   Yamamoto, Tetsuji ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b PEKING UNIVERSITY   (China)

Author keywords

Bisphosphonate; Callus remodeling; Fracture healing; Osteoporosis; Vitamin D analogue

Indexed keywords

2BETA (3 HYDROXYPROPOXY)CALCITRIOL; ALENDRONIC ACID; MEDIUM CHAIN TRIACYLGLYCEROL; SODIUM CHLORIDE; 2 (3 HYDROXYPROPOXY) 1,25 DIHYDROXYVITAMIN D3; 2-(3-HYDROXYPROPOXY)-1,25-DIHYDROXYVITAMIN D3; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITRIOL; DRUG DERIVATIVE; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CALLUS; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EVALUATION; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOTOMY; RADIOGRAPHY; RAT; TREATMENT DURATION; X RAY; ANIMAL; BONE REMODELING; CYTOLOGY; FEMUR; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACID PHOSPHATASE; ANIMALS; BONE REMODELING; BONY CALLUS; CALCITRIOL; DISEASE MODELS, ANIMAL; FEMALE; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; ISOENZYMES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33751551706     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.07.023     Document Type: Article

References (29)

1. Li J., Mori S., Kaji Y., Mashiba T., Kawanishi J., and Norimatsu H. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J. Bone Miner. Res. 14 (1999) 969-979
2. Li J., Mori S., Kaji Y., Kawanishi J., Akiyama T., and Norimatsu H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J. Bone Miner. Res. 15 (2000) 2042-2051
3. Li C., Mori S., Li J., Kaji Y., Akiyama T., Kawanishi J., et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J. Bone Miner. Res. 16 (2001) 429-436
4. Cao Y., Mori S., Mashiba T., Westmore M.S., Ma L., Sato M., et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J. Bone Miner. Res. 17 (2002) 2237-2246
5. Komatsubara S., Mori S., Mashiba T., Nonaka K., Seki A., Akiyama T., et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36 (2005) 678-687
6. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calif. Tissue Int. 54 (1994) 370-376
7. Raisz L.G., Trunmel C.L., Holick M.F., and Deluca H.F. 1,25-dihydroxycholecalkciferol: a potent stimulator of bone resorption in tissue culture. Science 175 (1972) 768-769
8. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new numbers of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20 (1999) 345-357
9. Shira-ishi A., Higashi S., Ohkawa H., Kubodera N., Hirasawa T., Ezawa I., et al. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calif. Tissue Int. 65 (1999) 311-316
10. 3 derivative, on calcium metabolism. Biochem. Biophys. Res. Commun. 163 3 (1989) 1444-1449
11. 3 is a potent inhibitor of bone resorption in aged estrogen-deficient rats. J. Bone Miner. Res. 19(s) (2004) s323 [ASBMR 26th Annual Meeting Abstract SU500]
12. 3 (ED-71) for 6 months increases bone mass in ovariectomized cynomolgus monkey. J. Bone Miner. Res. 19(s) (2004) s324 [ASBMR 26th Annual Meeting Abstract SU501]
13. Uchiyama Y., Higuchi Y., Takeda T., Masaki A., Shira-ishi A., Sato K., et al. ED-71, a vitamin D analogue, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 30 (2002) 582-588
14. Matsumoto T., Miki T., Hagino H., Sugimoto T., Okamoto S., Hirota T., et al. A new active vitamin, ED-71, increases bone mass in osteoporotic patients under supplementation: a randomized, double-blinded, placebo-controlled clinical trial. JCEM 90 9 (2005) 5031-5036
15. Rodan G.A., and Fleisch H.A. Bisphosphonates: mechanism of action. J. Clin. Invest. 97 (1996) 2692-2696
16. Russell R.G., and Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again. Bone 5 (1999) 97-106
17. Chavassieux P.M., Arlot M.E., Reda C., Wei L., Yates A.J., and Meunier P.J. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J. Clin. Invest. 100 (1997) 1475-1480
18. Turner C.H., and Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 14 (1993) 595-608
19. Huo M.H., Troiano N.W., Pelker R.R., Gundberg C.M., and Friedlaender G.E. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J. Orthop. Res. 9 (1991) 383-390
20. Mckibbin B. The biology of fracture healing in long bones. J. Bone Joint Surg. Br. 60B (1978) 150-162
21. Schenk R.K., and Hunziker E.B. Histologic and ultrastructural features of fracture healing. In: Brington C.T., Friedlaender G.E., and Lane J.M. (Eds). Bone Regeneration and Repair. 1st ed. (1994), American Academy of Orthopedic Surgeons, Rosemont, IL, USA 117-146
22. Einhorn T.A. The cell and molecular biology of fracture healing. Clin. Othop. 355S (1998) S7-S21
23. Frost H.M. The biology of fracture healing. Clin. Orthop. 248 (1998) 283-309
24. 3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif. Tissue Int. 54 (1994) 142-149
25. Shira-ishi A., Takeda K., Masaki T., Higuchi Y., Uchiyama Y., Kubodera N., et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis distinct actions from estrogen. J. Bone Miner. Res. 15 (2000) 770-779
26. Shibata T., Shira-ishi A., Sato T., Masaki T., Sasaki A., Masuda Y., et al. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. J. Bone Miner. Res. 17 4 (2002) 622-629
27. Murakami H., Takahashi N., Sasaki T., Udagawa N., Tanaka S., Nakamura I., et al. A possible mechanism of specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17 (1995) 137-144
28. Sato M., and Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J. Bone Miner. Res. 5 (1990) 31-40
29. Hughes D.E., MacDocald B.R., Russell R.G., and Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term culture of human bone marrow. J. Clin. Invest. 83 (1989) 1930-1935